Dr Emma Reid
- Lecturer (Cardiovascular & Metabolic Health)
Emma graduated from the University of Glasgow with a BSc Physiology in 2005 and returned to graduate with First-Class Honours in Neuroscience in 2008, where she was also awarded the prestigious Ede & Ravenscroft Prize for Biology, as the top performing student in the Faculty of Biomedical and Life Sciences. She remained at the University of Glasgow to undertake a PhD in Clinical Neuroscience within the Faculty of Medicine, where she investigated the efficacy of novel treatments for ischaemic stroke, using clinically relevant experimental models.
Following completion of her PhD, Emma then moved to Northern Ireland, where she worked with Alzheimer’s disease models at the University of Ulster, followed by a 3-year postdoctoral position at Queen’s University Belfast. While in Belfast, Emma’s research focused on evaluating the potential of cell therapy to promote vascular repair in models of oxygen-induced retinopathy, branch retinal vein occlusion, and diabetic retinopathy. In 2014, Emma returned to the University of Glasgow to continue her earlier research on developing new treatments for ischaemic stroke and developed an interest in teaching at this time. In 2017, Emma became a Lecturer within the former School of Life Sciences and is now based within the School of Cardiovascular & Metabolic Health.
Emma’s research interests focus on identifying novel therapeutic strategies to treat ischaemic disease, particularly cerebral and retinal ischaemia. She has a particular interest in using clinically relevant models, which incorporate risk factors such as hypertension and diabetes. Emma’s previous research has investigated the therapeutic potential of endothelial progenitor cells in models of oxygen-induced retinopathy, branch retinal vein occlusion, and diabetic retinopathy. She later evaluated the efficacy of Angiotensin (1-7) in improving stroke outcome in a hypertensive model of experimental stroke and investigated the therapeutical potential of the NMDA receptor antagonist, memantine, using the same preclinical model. Emma also has a keen interest in brain imaging, specifically MRI, and has extensively used diffusion, perfusion, and T2 weighted MRI in her stroke research.
Emma was course coordinator of the third year of the Neuroscience degree programme for 5 years (2018-2023) and currently coordinates the Widening Participation HNC Articulation programme, which provides access to Higher Education to students from partner Further Education Colleges. Emma also contributes to teaching delivery and assessment across a wide range of undergraduate and postgraduate courses within the College of Medical, Veterinary & Life Sciences, and supervises undergraduate research projects.
- Biology 1A (BIOL1001)
- Human Biological Processes 2C (BIOL2043)
- Anatomy 3A and 3B (BIOL4230, BIOL4231)
- Human Biology 3A and 3B (BIOL4228, BIOL4229)
- Physiology 3A and 3B (BIOL4238, BIOL4239)
- Neuroscience 3A and 3B (BIOL4234, BIOL4235)
- Anatomical Imaging Techniques (Level 4 course option, BIOL4275)
- Bio-Imaging in the Life Sciences (Level 4 course option, BIOL4190)
- Contemporary Issues in Neuroscience (Level 4 course option, BIOL4258)
- Diseases of the Nervous System (Level 4 course option, BIOL4038)
- Neuromodulation & Synaptic Plasticity (Level 4 course option, BIOL4279)
- MSc Biomedical Sciences (Bio-Imaging for Research Scientists course, BIOL5261)
Professional activities & recognition
Professional & learned societies
- 2020: Fellow, The Higher Education Academy
- 2014 - 2017: Member, The International Society for Cerebral Blood Flow & Metabolism
- 2012 - 2015: Member, The Association for Research in Vision and Ophthalmology
Selected international presentations
- 2017: BRAIN & BRAIN PET (Berlin, Germany)
- 2016: International Symposium on Neuroprotection & Neurorepair (Leipzig, Germany)
- 2014: ARVO (Orlando, USA)
- 2013: ARVO (Seattle, USA)
- 2012: Vascular Progenitors in Biology & Medicine (Fribourg, Switzerland)
- 2011: BRAIN & BRAIN PET (Barcelona, Spain)